Literature DB >> 20462634

US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up.

Scott H Sicherer1, Anne Muñoz-Furlong, James H Godbold, Hugh A Sampson.   

Abstract

BACKGROUND: Allergy to peanuts and tree nuts (TNs) is the leading cause of fatal allergic reactions in the United States, and the prevalence appears to be increasing.
OBJECTIVES: We sought to determine the US prevalence of self-reported peanut, TN, and sesame allergy in 2008 and compare results with comparable surveys conducted in 1997 and 2002.
METHODS: A nationwide, cross-sectional, random telephone survey for peanut and TN allergy was conducted with a previously used questionnaire, with additional questions about sesame.
RESULTS: A total of 5,300 households (13,534 subjects) were surveyed (participation rate, 42% vs 52% in 2002 and 67% in 1997). Peanut allergy, TN allergy, or both was reported by 1.4% of subjects (95% CI, 1.2% to 1.6%) compared with 1.2% in 2002 and 1.4% in 1997. For adults, the prevalence was 1.3% (95% CI, 1.1% to 1.6%), which was not significantly different from prior surveys. However, the prevalence of peanut or TN allergy for children younger than 18 years was 2.1% (95% CI, 1.6% to 2.7%) compared with 1.2% in 2002 (P = .007) and 0.6% in 1997 (P < .001). The prevalence of peanut allergy in children in 2008 was 1.4% (95% CI, 1.0% to 1.9%) compared with 0.8% in 2002 (P = not significant) and 0.4% in 1997 (P < .0001). The prevalence of childhood TN allergy increased significantly across the survey waves (1.1% in 2008, 0.5% in 2002, and 0.2% in 1997). Sesame allergy was reported by 0.1% (95% CI, 0.0% to 0.2%).
CONCLUSIONS: Although caution is required in comparing surveys, peanut allergy, TN allergy, or both continue to be reported by more than 1% of the US population (eg, >3 million subjects) and appear to be increasingly reported among children over the past decade. Sesame allergy is reported much less commonly. Copyright (c) 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20462634     DOI: 10.1016/j.jaci.2010.03.029

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  229 in total

Review 1.  Diagnosis of food allergy: epicutaneous skin tests, in vitro tests, and oral food challenge.

Authors:  Jay A Lieberman; Scott H Sicherer
Journal:  Curr Allergy Asthma Rep       Date:  2011-02       Impact factor: 4.806

Review 2.  Future therapies for food allergies.

Authors:  Anna Nowak-Węgrzyn; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2011-01-31       Impact factor: 10.793

Review 3.  The future of food allergy therapeutics.

Authors:  Michele Henson; A Wesley Burks
Journal:  Semin Immunopathol       Date:  2012-06-27       Impact factor: 9.623

Review 4.  Early life precursors, epigenetics, and the development of food allergy.

Authors:  Xiumei Hong; Xiaobin Wang
Journal:  Semin Immunopathol       Date:  2012-07-10       Impact factor: 9.623

5.  Ara h 6 complements Ara h 2 as an important marker for IgE reactivity to peanut.

Authors:  Audrey E Koid; Martin D Chapman; Robert G Hamilton; Ronald van Ree; Serge A Versteeg; Stephen C Dreskin; Stef J Koppelman; Sabina Wünschmann
Journal:  J Agric Food Chem       Date:  2013-12-26       Impact factor: 5.279

Review 6.  Epidemiology and Burden of Food Allergy.

Authors:  Christopher M Warren; Jialing Jiang; Ruchi S Gupta
Journal:  Curr Allergy Asthma Rep       Date:  2020-02-14       Impact factor: 4.806

Review 7.  Novel approaches to food allergy.

Authors:  Yao-Hsu Yang; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2014-06       Impact factor: 8.667

8.  IgE, but not IgG4, antibodies to Ara h 2 distinguish peanut allergy from asymptomatic peanut sensitization.

Authors:  X Hong; D Caruso; R Kumar; R Liu; X Liu; G Wang; J A Pongracic; X Wang
Journal:  Allergy       Date:  2012-10-25       Impact factor: 13.146

9.  Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.

Authors:  Sarita U Patil; Johanna Steinbrecher; Agustin Calatroni; Neal Smith; Alex Ma; Bert Ruiter; Yamini Virkud; Michael Schneider; Wayne G Shreffler
Journal:  J Allergy Clin Immunol       Date:  2019-08-01       Impact factor: 10.793

10.  Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective.

Authors:  Brian P Vickery; Jelena P Berglund; Caitlin M Burk; Jason P Fine; Edwin H Kim; Jung In Kim; Corinne A Keet; Michael Kulis; Kelly G Orgel; Rishu Guo; Pamela H Steele; Yamini V Virkud; Ping Ye; Benjamin L Wright; Robert A Wood; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2016-08-10       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.